press coverage

  • September 22, 2020  
  • September 18, 2020  
  • September 17, 2020  
  • August 6, 2020  
  • December 6, 2019  
  • February 8, 2019  

    Promising Developments for Brain Tumor Drug ONC201

    In September, we announced our collaboration with Musella Foundation, xCures, and Oncoceutics to help patients access ONC201, a potential new treatment for a type of brain tumor known as diffuse intrinsic pontine glioma (DIPG), as well as other gliomas with a genetic mutation known as H3 K27M. Since then, several news stories have reported promising developments for ONC201. Check out the coverage: The Philadelphia Inquirer: “Cancer therapy shows promise for… Read more »

  • October 12, 2017  
  • June 10, 2017  
  • June 10, 2017  
  • July 20, 2015